Hemoglobin A1c (HbA1c) Testing Global Market Opportunities And Strategies To 2034

Description

Hemoglobin A1c (HbA1c) testing refers to the diagnostic and monitoring tools used to measure the average blood glucose levels over the past two to three months. The test is used to diagnose diabetes, prediabetes, and evaluate the effectiveness of treatment plans in people with diabetes. It is an essential component of diabetes management and is widely used by healthcare providers to assess how well diabetes is being controlled.

The HbA1C testing market consists of sales, by entities (organizations, sole traders and partnerships), of HbA1C testing that provides a reliable indication of blood sugar levels by quantifying the percentage of glycosylated hemoglobin in the blood, offering an essential parameter for long-term glucose monitoring. The testing is primarily used by endocrinologists, general practitioners and other healthcare professionals in hospitals, clinics and diagnostic laboratories. Patients themselves may also use these tests in homecare settings for self-monitoring purposes.

The global hemoglobin A1c (HbA1c) testing market was valued at $1,410.48 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 5.00%.

Increasing Focus On Personalized Medicine

The increasing focus on personalized medicine supported the growth of the hemoglobin A1c (HbA1c) testing market during the historic period. HbA1c testing offers a long-term view of blood glucose levels over 2-3 months, enabling healthcare providers to optimize diabetes management. By integrating pharmacogenomics, personalized medicine adjusts drug selection and dosing based on genetic profiles. HbA1c results guide therapy modifications, enhancing treatment efficacy. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system, more than 75,000 genetic testing products and 300 personalized medicines were present on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, in 2022, personalized medicines accounted for 34% of new drug approvals by the US Food and Drug Administration and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, the increasing focus on personalized medicine drove the growth of the hemoglobin A1c (HbA1c) testing market.

Advancements In Testing With Focus on High-Performance Liquid Chromatography (HPLC) Analyzers for Enhanced Diabetes Management

Leading companies in the hemoglobin A1c (HbA1c) testing market are concentrating on creating innovative solutions, including high-performance liquid chromatography (HPLC) analyzers, to enhance the accuracy, speed, and efficiency of diabetes management. HPLC analyzers are utilized to accurately measure the percentage of HbA1c in blood samples, delivering precise data for the diagnosis and ongoing monitoring of diabetes. For instance, in June 2021, Trivitron Healthcare, an India-based medical device company, launched two innovative high-performance liquid chromatography (HPLC) analyzers, the NANO H5 and NANO H110, designed for the rapid detection of glycated hemoglobin (HbA1c) and hemoglobin variants. These analyzers aim to enhance diabetes management and thalassemia diagnostics by providing results in under three minutes. The NANO H5 is a compact, fully automated HPLC analyzer that utilizes ion exchange liquid chromatography for the quantitative determination of glycated hemoglobin (HbA1c) in whole human blood. Like the NANO H5, the NANO H110 is also a compact and automated HPLC analyzer but features a dual test mode that allows for both HbA1c testing and Hb variant detection.

The global hemoglobin A1c (HbA1c) testing market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up 18.1% of the total market in 2023.

Hemoglobin A1c (HbA1c) Testing Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global hemoglobin A1c (HbA1c) testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for hemoglobin A1c (HbA1c) testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The hemoglobin A1c (HbA1c) testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider hemoglobin A1c (HbA1c) testing market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by product type, by technology and by end user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the hemoglobin A1c (HbA1c) testing market.
Global Market Size And Growth Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by product type, by technology and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for hemoglobin A1c (HbA1c) testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type: Laboratory Based Testing; Point Of Care (PoC) Testing
2) By Product Type: Reagents And Kits; Instruments; Software And Services
3) By Technology: Immunoassays; Chromatography; Enzymatic Assays; Boronate Affinity Chromatography; High Performance Liquid Chromatography; Other Technologies
4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Settings; Other End Users
Companies Mentioned: Danaher Corporation (Beckman Coulter, Inc.); F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; Abbott Laboratories; Bio-Rad Laboratories, Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; Thailand; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; hemoglobin A1c (HbA1c) testing indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1503

1 Executive Summary

1.1 Hemoglobin A1c (HbA1c) Testing - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Hemoglobin A1c (HbA1c) Testing Market Definition And Segmentations
6.4 Market Segmentation By Type
- 6.4.1 Laboratory Based Testing
- 6.4.2 Point Of Care (PoC) Testing
6.5 Market Segmentation By Product Type
- 6.5.1 Reagents And Kits
- 6.5.2 Instruments
- 6.5.3 Software And Services
6.6 Market Segmentation By Technology
- 6.6.1 Immunoassays
- 6.6.2 Chromatography
- 6.6.3 Enzymatic Assays
- 6.6.4 Boronate Affinity Chromatography
- 6.6.5 High Performance Liquid Chromatography
- 6.6.6 Other Technologies
6.7 Market Segmentation By End User
- 6.7.1 Hospitals And Clinics
- 6.7.2 Diagnostic Laboratories
- 6.7.3 Homecare Settings
- 6.7.4 Other End Users

7 Major Market Trends

7.1 Launch Of Next-Generation Point-Of-Care Device Enhances Diabetes Management And Early Diagnosis
7.2 Empowering Health With At-Home Diabetes Risk (HbA1c) Collection Kits
7.3 Advancements In Testing With Focus on High-Performance Liquid Chromatography (HPLC) Analyzers for Enhanced Diabetes Management
7.4 Innovations In Hemoglobin A1c (HbA1c) Testing Using Menstrual Blood

8 Hemoglobin A1c (HbA1c) Testing Market - Macro Economic Scenario

8.1 COVID-19 Impact On The Hemoglobin A1c (HbA1c) Testing Market
8.2 Impact Of The War In Ukraine On The Hemoglobin A1c (HbA1c) Testing Market
8.3 Impact Of High Inflation On The Hemoglobin A1c (HbA1c) Testing Market

9 Global Market Size and Growth

9.1 Market Size
9.2 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 9.2.1 Market Drivers 2019 - 2024
- 9.2.2 Market Restraints 2019 - 2024
9.3 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
- 9.3.1 Market Drivers 2024 - 2029
- 9.3.2 Market Restraints 2024 - 2029

10 Global Hemoglobin A1c (HbA1c) Testing Volume

10.1 Historic Market Growth, 2019 - 2024, Volume (Million Units)
10.2 Forecast Market Growth, 2024 - 2029, 2034F, Volume (Million Units)

11 Global Hemoglobin A1c (HbA1c) Testing Market Segmentation

11.1 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.2 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.3 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Hemoglobin A1c (HbA1c) Testing Market, Regional and Country Analysis

12.1 Global Hemoglobin A1c (HbA1c) Testing Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.2 Global Hemoglobin A1c (HbA1c) Testing Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Asia-Pacific Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Investments
- 13.2.11 Major Companies
13.3 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.7 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.8 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market: Country Analysis
13.9 Thailand Market
13.10 Summary
13.11 Market Overview
- 13.11.1 Country Information
- 13.11.2 Market Information
- 13.11.3 Background Information
- 13.11.4 Government Initiatives
- 13.11.5 Regulations
- 13.11.6 Regulatory Bodies
- 13.11.7 Major Associations
- 13.11.8 Taxes Levied
- 13.11.9 Corporate Tax Structure
- 13.11.10 Investments
- 13.11.11 Major Companies
13.12 Thailand Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.13 Thailand Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.14 Thailand Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.15 Thailand Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.16 Thailand Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.17 China Market
13.18 Summary
13.19 Market Overview
- 13.19.1 Country Information
- 13.19.2 Market Information
- 13.19.3 Background Information
- 13.19.4 Government Initiatives
- 13.19.5 Regulations
- 13.19.6 Regulatory Bodies
- 13.19.7 Major Associations
- 13.19.8 Taxes Levied
- 13.19.9 Corporate Tax Structure
- 13.19.10 Investments
- 13.19.11 Major Companies
13.20 China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.21 China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.22 China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.23 China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.24 China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.25 India Market
13.26 India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.27 India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.28 India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.29 India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.30 India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.31 Japan Market
13.32 Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.33 Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.34 Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.35 Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.36 Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.37 Australia Market
13.38 Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.39 Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.40 Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.41 Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.42 Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.43 Indonesia Market
13.44 Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.45 Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.46 Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.47 Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.48 Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.49 South Korea Market
13.50 South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.51 South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.52 South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.53 South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.54 South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 Western Europe Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate tax structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.7 Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.8 Western Europe Hemoglobin A1c (HbA1c) Testing Market: Country Analysis
14.9 UK Market
14.10 UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.14 UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.15 Germany Market
14.16 Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.19 Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.20 Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.21 France Market
14.22 France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.23 France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.24 France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.25 France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.26 France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.27 Italy Market
14.28 Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.29 Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.30 Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.31 Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.32 Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.33 Spain Market
14.34 Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.35 Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.36 Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.37 Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.38 Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 Eastern Europe Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Major Companies
15.3 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.7 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.8 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market: Country Analysis
15.9 Russia Market
15.10 Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.11 Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.12 Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.13 Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.14 Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 North America Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
16.3 North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.6 North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.7 North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.8 North America Hemoglobin A1c (HbA1c) Testing Market: Country Analysis
16.9 USA Market
16.10 Summary
16.11 Market Overview
- 16.11.1 Country Information
- 16.11.2 Market Information
- 16.11.3 Background Information
- 16.11.4 Government Initiatives
- 16.11.5 Regulations
- 16.11.6 Regulatory Bodies
- 16.11.7 Major Associations
- 16.11.8 Taxes Levied
- 16.11.9 Corporate Tax Structure
- 16.11.10 Investments
- 16.11.11 Major Companies
16.12 USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.13 USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.14 USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.15 USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.16 USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.17 Canada Market
16.18 Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.19 Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.20 Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.21 Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.22 Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 South America Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Investments
- 17.2.11 Major Companies
17.3 South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.6 South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.7 South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.8 South America Hemoglobin A1c (HbA1c) Testing Market: Country Analysis
17.9 Brazil Market
17.10 Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.11 Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.12 Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.13 Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.14 Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Middle East Market

18.1 Summary
18.2 Market Overview
- 18.2.1 Region Information
- 18.2.2 Market Information
- 18.2.3 Background Information
- 18.2.4 Government Initiatives
- 18.2.5 Regulations
- 18.2.6 Regulatory Bodies
- 18.2.7 Major Associations
- 18.2.8 Taxes Levied
- 18.2.9 Corporate Tax Structure
- 18.2.10 Investments
- 18.2.11 Major Companies
18.3 Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18.4 Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18.5 Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18.6 Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18.7 Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

19 Africa Market

19.1 Summary
19.2 Market Overview
- 19.2.1 Region Information
- 19.2.2 Market Information
- 19.2.3 Background Information
- 19.2.4 Government Initiatives
- 19.2.5 Regulations
- 19.2.6 Regulatory Bodies
- 19.2.7 Major Associations
- 19.2.8 Taxes Levied
- 19.2.9 Corporate Tax Structure
- 19.2.10 Investments
- 19.2.11 Major Companies
19.3 Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
19.4 Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
19.5 Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
19.6 Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
19.7 Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

20 Competitive Landscape And Company Profiles

20.1 Company Profiles
20.2 Danaher Corporation (Beckman Coulter, Inc.)
- 20.2.1 Company Overview
- 20.2.2 Products And Services
- 20.2.3 Financial Overview
20.3 F. Hoffman-La Roche Ltd
- 20.3.1 Company Overview
- 20.3.2 Products And Services
- 20.3.3 Business Strategy
- 20.3.4 Financial Overview
20.4 Siemens Healthineers AG
- 20.4.1 Company Overview
- 20.4.2 Products And Services
- 20.4.3 Business Strategy
- 20.4.4 Financial Overview
20.5 Abbott Laboratories
- 20.5.1 Company Overview
- 20.5.2 Products And Services
- 20.5.3 Business Strategy
- 20.5.4 Financial Overview
20.6 Bio-Rad Laboratories, Inc
- 20.6.1 Company Overview
- 20.6.2 Products And Services
- 20.6.3 Financial Overview

21 Other Major And Innovative Companies

21.1 Randox Laboratories Ltd
- 21.1.1 Company Overview
- 21.1.2 Products and Services
21.2 Thermo Fisher Scientific Inc
- 21.2.1 Company Overview
- 21.2.2 Products and Services
21.3 Sysmex Corporation
- 21.3.1 Company Overview
- 21.3.2 Products and Services
21.4 ARKRAY Inc
- 21.4.1 Company Overview
- 21.4.2 Products and Services
21.5 Tosoh Corporation
- 21.5.1 Company Overview
- 21.5.2 Products and Services
21.6 Agappe Diagnostics Ltd
- 21.6.1 Company Overview
- 21.6.2 Products and Services
21.7 A. Menarini Diagnostics srl
- 21.7.1 Company Overview
- 21.7.2 Products and Services
21.8 EKF Diagnostics Holdings plc
- 21.8.1 Company Overview
- 21.8.2 Products and Services
21.9 SD Biosensor
- 21.9.1 Company Overview
- 21.9.2 Products and Services
21.10 Sekisui Diagnostics LLC
- 21.10.1 Company Overview
- 21.10.2 Products and Services
21.11 PTS Diagnostics
- 21.11.1 Company Overview
- 21.11.2 Products and Services
21.12 SEBIA
- 21.12.1 Company Overview
- 21.12.2 Products and Services
21.13 Trinity Biotech PLC
- 21.13.1 Company Overview
- 21.13.2 Products and Services
21.14 Osang Healthcare Co. Ltd
- 21.14.1 Company Overview
- 21.14.2 Products and Services
21.15 Diazyme Laboratories
- 21.15.1 Company Overview
- 21.15.2 Products and Services

22 Competitive Benchmarking

23 Competitive Dashboard

24 Key Mergers And Acquisitions

24.1 Roche Holding AG Acquired LumiraDx To Enhance Primary Care Diagnostics
24.2 Tosoh Corporation Acquired Semba Biosciences Inc. To Enhance Biologics Purification and HbA1c Testing

25 Opportunities And Strategies

25.1 Global Hemoglobin A1c (HbA1c) Testing Market In 2029 - Countries Offering Most New Opportunities
25.2 Global Hemoglobin A1c (HbA1c) Testing Market In 2029 - Segments Offering Most New Opportunities
25.3 Global Hemoglobin A1c (HbA1c) Testing Market In 2029 - Growth Strategies
- 25.3.1 Market Trend Based Strategies
- 25.3.2 Competitor Strategies

26 Hemoglobin A1c (HbA1c) Testing Market, Conclusions And Recommendations

26.1 Conclusions
26.2 Recommendations
- 26.2.1 Product
- 26.2.2 Place
- 26.2.3 Price
- 26.2.4 Promotion
- 26.2.5 People

27 Appendix

27.1 Geographies Covered
27.2 Market Data Sources
27.3 Research Methodology
27.4 Currencies
27.5 The Business Research Company
27.6 Copyright and Disclaimer